• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 5
  • 3
  • 1
  • 1
  • 1
  • Tagged with
  • 12
  • 10
  • 7
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

A retrospective descriptive study of pain scores in the pre-diabetic patients on metformin

Moore, Michele Nakamura 01 July 2015 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Objectives: The purpose was to evaluate pain scores (SF-36 BPS) among pre-diabetic patients on metformin or placebo to determine if patients on metformin therapy report less pain (higher SF-36 BPS) than patients on placebo. Study design: A descriptive retrospective review of pain scores was conducted using secondary data analyses of the Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) conducted from 1996 to 2008. Patients were randomly assigned to placebo, low (850 mg/day) or high dose (1700 mg/day) metformin groups. Pain scores using the SF-36 BPS standard version were taken before randomization and annually (year one through four). Results: Out of 3,819 patients that participated in the original study, 1,056 patients met the current study criteria. The metformin group included 506 patients and the placebo group included 550 patients. With an alpha level of 0.05 for all analyses, baseline pain scores between the metformin group and placebo group showed no significant difference. Year two showed significance between placebo and metformin pain scores (75.2 vs 78.6). All other years were not significant. Comparing low and high dose metformin and placebo groups, years one, two and three displayed significant differences in pain scores. In years one and two, the high dose metformin group reported less pain than the placebo group (80.7 vs 77.7; 80.1 vs 75.2) and the low dose metformin group (80.7 vs 71.8; 80.1 vs 68.6). In year three, the high dose metformin group had less pain than the low dose metformin group (78.4 vs 70.5).
2

Cultural perceptions of American Indian women in Southcentral Montana regarding pre-diabetic education

Hartford, Lori Ann. January 2008 (has links) (PDF)
Thesis (M Nursing)--Montana State University--Bozeman, 2008. / Typescript. Chairperson, Graduate Committee: Christina Sieloff. Includes bibliographical references (leaves 47-51).
3

Effects of a Lifestyle Intervention on Brain-derived Neurotrophic Factor (Bdnf) in Obese Latino Youth with Pre-Diabetes

January 2016 (has links)
abstract: Latino youth have substantially higher rates of obesity and T2D than their white peers. The higher prevalence of obesity and T2D among Latino youth places them at greater risk for cognitive dysfunction, an urgent and serious health threat to the United States. Exercise has been the cornerstone to combat the negative effects of obesity, diabetes and recent research also supports this effects for preventing cognitive dysfunction. A wealth of evidence suggests that a mediating mechanism linking exercise with brain health is BDNF, a cognitive biomarker that increases in the brain with exercise. BDNF is the most abundant neurotrophic factor that supports growth, survival and synaptic plasticity of neurons, all vital for cognitive function and brain health. The present study sought to investigate the effects of a 12-week lifestyle intervention of physical activity and lifestyle education on serum BDNF, in obese pre diabetic Latino youth. A total of twelve obese pre diabetic Latino youth were selected from a larger RCT sample to be the focus for this analysis. After an overnight fast, a serum concentration was collected from all youth to be used for the BDNF analysis. In addition, the following cardio metabolic measures were also at taken at baseline and post intervention: Submaximal VO2max, medical and family history questionnaire, anthropometric, fasting glucose and a 2-hour oral glucose tolerance test (OGTT). A 12-weeks Lifestyle Intervention that involved a progressive moderate to high intensity exercise component and lifestyle education program did not significantly change serum BDNF levels in obese pre diabetic Latino youth. In conclusion, the variation of our serum BDNF results are highly speculative at this time, therefore the need for future investigations is crucial. / Dissertation/Thesis / Masters Thesis Exercise and Wellness 2016
4

(Pre)diabetic Nation: Diagnosing Risk and Medicalizing Prevention in Mexico

Vasquez, Emily January 2021 (has links)
While the strict boundaries and ideal measurement of prediabetes remain contested internationally, health officials and private donors in the health sector in Mexico have promoted its diagnosis and treatment as a key strategy in the nation’s fight against diabetes. This dissertation examines the circumstances under which officials have come to view prediabetes diagnosis as a feasible strategy for the Mexican context and the implications of treating individuals, situated across deep lines of social inequality, who are not yet sick, but deemed at risk of developing disease. Set against Mexico’s chronic disease crisis, where diabetes was declared a national sanitary emergency in 2016 and where experts suggest up to 40% of adults likely have prediabetes, this dissertation engages the prediabetes diagnosis as a lens through which to illuminate the social forces, values, and assumptions currently at work in Mexican health politics. The project foregrounds the dilemmas raised by highly medicalized and clinic-based approaches to chronic disease prevention and mobilizes the case of prediabetes in Mexico to illustrate the broader convergence of the fields of biomedicine and public health. Centered in Mexico City, field research for this project was carried out over 30 months, employing multi-sited ethnographic methods, including 106 in-depth interviews (47 of which were with individuals diagnosed with prediabetes and their families), observations of 382 medical exams, and attendance at 71 scientific, community health, and activist-hosted events. Alongside the powerful influence of the pharmaceutical industry, my findings bring to the fore a new set of actors and circumstances involved in the circulation of predisease diagnosis to this developing country context. These include (1) the epistemological limits imposed by “projectification” in global health science, (2) the influence and ideologies of an elite-mega philanthropist and his Foundation’s conviction that technological innovation will foster better health, and (3) local and global imaginaries that endorse the power of Big Data analytics to solve a plethora of development challenges. Further, in tracing the enactment of the prediabetes diagnosis across public and private clinics, I show that the pre-disease condition that economic elites experience when they are diagnosed contrasts sharply with that experienced by working class and low-income patients—I argue that in practice, prediabetes is multiple and its diagnosis amplifies existing social inequities. I also show that the emotional and ethical responses to the diagnosis among patients can differ substantially, particularly across socioeconomic divides. I argue that in Mexico, increased access to risk knowledge does not foster a spirit of “optimization” among the majority of Mexicans, but rather an alternative ethic, which I term “strategic preservation.” Finally, I show that many health experts in Mexico share a common set of values and norms in thinking about diabetes risk. On a macro level, they discursively link the looming threat of prediabetes, diabetes risk, and diabetes itself to the nation’s potentially disastrous macroeconomic future, effectively charging individuals with the responsibility to mitigate this threat through behavior and lifestyle modification. Health experts in this arena also frequently communicate the notion that the Mexican body itself is a key source of diabetes risk. I point to other elites in Mexico who, relying on a similar conception of the Mexican body, are investing in molecular technologies to better detect embodied diabetes risk, and to expand the reach and precision of medicalized prevention strategies in the future. These findings have implications for developing countries globally, which now bear the highest burden of chronic disease. Developing countries are already or will soon grapple with a similar epidemiological crisis and, as this occurs, Mexico’s strategies and experience will set precedents and establish key paradigms for public health action globally. With this in mind, I call for the disentanglement of expertise between the fields of biomedicine and public health and for a turn toward more structural, indeed socially radical, policies for chronic disease prevention at the population level.
5

Prevalência de pré-diabetes e fatores de risco para diabetes mellitus tipo 2 em adolescentes e características associadas a esta condição

Medeiros, Thaisy Garcia de Oliveira 31 May 2016 (has links)
Submitted by Jean Medeiros (jeanletras@uepb.edu.br) on 2018-05-11T11:39:10Z No. of bitstreams: 1 PDF - Thaisy Garcia de Oliveira.pdf: 24734749 bytes, checksum: c809add18e9f0408b53a222d75f4fddd (MD5) / Approved for entry into archive by Secta BC (secta.csu.bc@uepb.edu.br) on 2018-05-23T16:49:58Z (GMT) No. of bitstreams: 1 PDF - Thaisy Garcia de Oliveira.pdf: 24734749 bytes, checksum: c809add18e9f0408b53a222d75f4fddd (MD5) / Made available in DSpace on 2018-05-23T16:49:58Z (GMT). No. of bitstreams: 1 PDF - Thaisy Garcia de Oliveira.pdf: 24734749 bytes, checksum: c809add18e9f0408b53a222d75f4fddd (MD5) Previous issue date: 2016-05-31 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Introduction: Type 2 diabetes mellitus (DM2) has reached an increasing number of children and adolescents worldwide. In Brazil, there are few studies related to the prevalence of high risk for diabetes (prediabetes) and associated factors in this public. Objective: To determine the prevalence of prediabetes and risk factors for type 2 diabetes mellitus among adolescent and characteristics associated with this condition. Methods: Transversal research with a quantitative approach, involving 553 adolescents (15-19 years) from public high schools in the city of Campina Grande, Paraíba. Data collection was conducted from September 2012 to June 2013, through the application form for obtaining demographic data, behavioral factors (sedentary lifestyle and physical activity) and family histor y of type 2 diabetes; conducting anthropometric (weight, height and abdominal circumference); measurement of blood pressure and blood collection (Glycated hemoglobin, fasting blood glucose and lipid profile). It was considered prediabetes the presence of HbA1c ≥ 5.7 and / or fasting glucose ≥ 100 mg / dL and, for evaluation of the presence of risk factors, it was adopted the criteria mentioned by the American Diabetes Association (ADA) and by the European Association for Diabetes Study. For classification of the group at risk for the development of T2DM it was considered the criteria adopted by ADA. Data were double entered and submitted for validation through the Epi Info 6.04 validate sub-program. Through the Statistical Package for Social Sciences (SPSS, version 22.0), a descriptive analysis of all variables was performed using the measurements of absolute and relative frequency. The distribution of these variables and association analysis took place according to the nutritional status and the presence or absence of abnormal HbA1C (prediabetes) among adolescents, using the chi-square test. For those variables that were associated with the prediabetic state, it was analyzed their independence in determining this condition, through the multivariate logistic regression test. All statistical analyzes considered the 95% confidence interval. Results: Among the adolescents evaluated, 19.3% were overweight / obese. Prediabetes was more common among those who were overweight (8.4%), but it was also present among those who were eutrophic (4.9%). In relation to the lifestyle, 53.4% were sedentary and 60.2% physically inactive. Among the risk factors recommended by the ADA, the most frequent were low HDL cholesterol (42.3%) and total cholesterol (21.0%). Only high triglyceride level was associated with prediabetes, but it did not appear as a predictor of this condition. Conclusions: The finding of a considerable prevalence of type 2 prediabetes among adolescents, including the eutrophic one, reinforces the importance of screening of this condition in this age group, regardless of nutritional status. It is important to conduct longitudinal studies to assess causality and the risk of developing type 2 diabetes among those with prediabetes. / Introdução: O diabetes mellitus tipo 2 (DM2) tem atingido um número crescente de crianças e adolescentes em todo o mundo. No Brasil, ainda são poucos os estudos relacionados à prevalência do risco elevado para o diabetes (pré-diabetes) e fatores associados nesse público. Objetivo: Verificar a prevalência de pré-diabetes e fatores de risco para Diabetes Mellitus tipo 2 em adolescentes e características associadas a esta condição. Material e Métodos: Pesquisa de caráter transversal, com abordagem quantitativa, envolvendo 553 adolescentes (15-19 anos) de escolas públicas de ensino médio do município de Campina Grande, Paraíba. A coleta dos dados foi realizada no período de setembro de 2012 a junho de 2013, através da aplicação de formulário para obtenção dos dados sociodemográficos, fatores comportamentais (sedentarismo e atividade física) e história familiar para o diabetes tipo 2; realização de antropometria (peso, estatura e circunferência abdominal); aferição da pressão arterial e coleta sanguínea (hemoglobina glicada A1C; glicemia de jejum e perfil lipídico). Considerou-se pré- diabetes a presença de HbA1c ≥ 5,7 e/ou glicemia de jejum ≥ 100mg/dL e, para avaliação da presença de fatores de risco, foram adotados os critérios mencionados pela American Diabetes Association (ADA) e pela Associação Europeia para o Estudo do Diabetes. Para classificação do grupo de risco para o desenvolvimento do DM2 foi considerado o critério adotado pela ADA. Os dados foram duplamente digitados e submetidos à validação no subprograma Validate do Epi Info 6.04. Através do Statistical Package for the Social Sciences (SPSS, versão 22.0), foi realizada uma análise descritiva de todas as variáveis, utilizando-se as medidas de frequência absoluta e relativa. A distribuição destas variáveis e análise de associação ocorreu de acordo com o estado nutricional e com a presença ou não de HbA1C alterada (pré-diabetes) entre os adolescentes, através do teste qui-quadrado. Para aquelas variáveis que apresentaram associação com o estado de pré-diabetes, analisou-se a independência delas na determinação dessa condição, utilizando-se o teste de regressão logística multivariada. Todas as análises estatísticas consideraram o intervalo de confiança de 95%. Resultados: Dos adolescentes avaliados, 19,3% tinham sobrepeso/obesidade. O pré- diabetes foi mais frequente entre os que tinham excesso de peso (8,4%), porém esteve presente entre os que eram eutróficos (4,9%). Em relação ao estilo de vida, 53,4% eram sedentários e 60,2% inativos fisicamente. Entre os fatores de risco preconizados pela ADA, os mais frequentes foram o colesterol HDL baixo (42,3%) e o colesterol total (21,0%). Apenas o triglicerídeo elevado esteve associado ao pré-diabetes, mas não se apresentou como fator preditor dessa condição. Conclusões: O achado de uma considerável prevalência de pré- diabetes tipo 2 entre os adolescentes, inclusive nos eutróficos, reforça a importância da triagem dessa condição nessa faixa etária, independente do estado nutricional. É importante a realização de estudos com delineamento longitudinal para avaliação de causa lidade e do risco de desenvolver o diabetes tipo 2 entre os que têm pré-diabetes.
6

Immunological profile and aspects of immunotherapy in type 1 diabetes /

Hjorth, Maria, January 2010 (has links) (PDF)
Diss. (sammanfattning) Linköping : Linköpings universitet, 2010. / Härtill 4 uppsatser.
7

Diabetessjuksköterskors erfarenheter och upplevelser av att jobba med förebyggande arbete för att förhindra utveckling av diabetes typ- 2 hos patienter med prediabetes : En kvalitativ studie

Pahlevan Moghaddam, Akram January 2021 (has links)
Bakgrund Förekomsten av diabetes typ-2 har ökat dramatiskt och cirka en halv miljard människor världen över har diabetes. Prediabetes är en av de riskfaktorer som ökar risken för att utveckla diabetes typ-2. Många studier har visat att livsstilsförändringar kan minska risken eller fördröja uppkomsten av diabetes typ-2. Syfte: Diabetessköterskors upplevelser och erfarenheter av att arbeta med metoder och insatser inom primärvården för att förhindra utveckling av diabetes typ-2 hos patienter med prediabetes Metod: Kvalitativ studie med semistrukturerade intervjuer. Resultat: Resultatet visade att screening och remittering till diabetessjuksköterskor för samtal med levnadsvanor och uppföljningar användes. Fem kategorier identifierades utifrån deras erfarenheter av förebyggande arbete: 1-upplevelser av att känna organisatoriskt stöd ger förutsättningar för preventivt arbete. 2-Upplevelser av att ha organisatoriska begränsningar eller hinder i patientarbete. 3-Rådgivning och stöd nämndes som mycket viktig del i deras patientarbete med livsstilsförändringar.4-Att ha verktyg underlättar preventionsarbete. 5-Upplevelser av att ha olika utmaningar och svårigheter i patientkommunikation- och information Slutsatser: Studien visade diabetessjuksköterskor hade olika erfarenheter avseende preventionsarbete utifrån de organisatoriska förutsättningar och förhållande de hade samt hur deras patientklienter såg ut vilket skulle kunna påverka deras preventionsarebete. Resursbrist och avsaknad av rutiner försvårade deras arbete. Därför är det viktigt att diabetessköterskor arbetsförhållande förbättras. Även utbildningar om befintliga rekommendationer eller riktlinjer avseende hälsofrämjande åtgärder är nödvändiga. / <p>Betyg i Ladok  210625.</p>
8

Regulation der Dual-leucine-zipper-kinase (DLK) durch "prädiabetische" Signale in endothelialen HUVEC-Zellen und die Bedeutung der DLK für die Angiogenese in einem Mausmodell / Regulation of dual-leucine-zipper-kinase (DLK) by prediabetic signals in endothelial HUVEC-cells and the role of DLK in angiogenesis in a mouse model

Krebs, Julia Meike 04 December 2013 (has links)
Diabetes mellitus und seine schwerwiegenden Folgen im Gefäßsystem stellen ein großes Problem der heutigen Gesellschaft dar. Ein wichtiger Aspekt der Erkrankung sind die Mikro- und Makroangiopathien, die im schlimmsten Fall zum Apoplex oder Tod führen. Es existieren bereits Hinweise, dass proinflammatorische Zytokine wie TNFα an der Entstehung des Diabetes mellitus beteiligt sind. TNFα führt zu einer Aktivierung der DLK und ihrer untergeordneten Kinase JNK, was in Betazellen zur Apoptose führt. In der vorliegenden Arbeit sollte die Rolle und Regulation der DLK in Gefäßzellen untersucht werden. Zusätzlich wurde die Angiogenese bei diät-induzierter Adipositas und Diabetes melitus in einem Mausmodell untersucht. Immunhistochemische Untersuchungen zeigen, dass die DLK in Endothelien und in glatten Muskelzellen der Aorta exprimiert wird. Um die Aktivierung und somit die Phosphorylierung der DLK zu untersuchen, wurde ein spezieller Antikörper, der an S-302 der DLK bindet, bei der Immunoblotanalyse verwendet. Eine Phosphorylierung an S-302 entspricht einer Aktivierung der DLK. Eine Behandlung von humanen Endothelzellen aus der Nabelschnurvene (HUVECs) mit TNFα zeigen eine Phosphorylierung der DLK und ihrer untergeordneten Kinase JNK. Eine Aktivierung durch Leptin oder dem vaskulären Wachstumsfaktor (VEGF) konnte hingegen nicht gezeigt werden. Zusätzlich zeigt eine Behandlung mit dem JNK-Inhibitor SP600125 eine verminderteTNFα-induzierte DLK- und JNK-Phosphorylierung, was zu der Annahme führt, dass in HUVECs die Aktivierung von JNK zu einer Phosphorylierung der DLK führt. Die Untersuchungen im Tiermodell lieferten Hinweise, dass die Regulation von TNFα ein entscheidender therapeutischer Ansatzpunkt bei der Entstehung endothelialer Dysfunktion darstellt. Es wurde gezeigt, dass das Ausschalten nur eines Allels der DLK einen messbaren Unterschied in Zusammenhang mit früher Kollateralbildung nach Ischämie erbringt. In Zusammenschau der vorliegenden Ergebnisse kann festgestellt werden, dass die Regulation der DLK durch TNFα in endothlialen Zellen einen wichtigen Aspekt in der Entwicklung der endothelialen Dysfunktion darstellt und dass die DLK als kollateralfördernde Kinase eine wichtige Rolle in der Revaskularisierung nach Ischämie spielt.
9

Effect of Periodontal Treatment on HbA1c among Patients with Prediabetes

Kocher, T., Holtfreter, B., Petersmann, A., Eickholz, P., Hoffmann, T., Kaner, D., Kim, T. S., Meyle, J., Schlagenhauf, U., Doering, S., Gravemeier, M., Prior, K., Rathmann, W., Harks, I., Ehmke, B., Koch, R. 29 October 2019 (has links)
Evidence is limited regarding whether periodontal treatment improves hemoglobin A1c (HbA1c) among people with prediabetes and periodontal disease, and it is unknown whether improvement of metabolic status persists >3 mo. In an exploratory post hoc analysis of the multicenter randomized controlled trial “Antibiotika und Parodontitis” (Antibiotics and Periodontitis)—a prospective, stratified, double-blind study—we assessed whether nonsurgical periodontal treatment with or without an adjunctive systemic antibiotic treatment affects HbA1c and high-sensitivity C-reactive protein (hsCRP) levels among periodontitis patients with normal HbA1c (≤5.7%, n = 218), prediabetes (5.7% < HbA1c < 6.5%, n = 101), or unknown diabetes (HbA1c ≥ 6.5%, n = 8) over a period of 27.5 mo. Nonsurgical periodontal treatment reduced mean pocket probing depth by >1 mm in both groups. In the normal HbA1c group, HbA1c values remained unchanged at 5.0% (95% CI, 4.9% to 6.1%) during the observation period. Among periodontitis patients with prediabetes, HbA1c decreased from 5.9% (95% CI, 5.9% to 6.0%) to 5.4% (95% CI, 5.3% to 5.5%) at 15.5 mo and increased to 5.6% (95% CI, 5.4% to 5.7%) after 27.5 mo. At 27.5 mo, 46% of periodontitis patients with prediabetes had normal HbA1c levels, whereas 47.9% remained unchanged and 6.3% progressed to diabetes. Median hsCRP values were reduced in the normal HbA1c and prediabetes groups from 1.2 and 1.4 mg/L to 0.7 and 0.7 mg/L, respectively. Nonsurgical periodontal treatment may improve blood glucose values among periodontitis patients with prediabetes (ClinicalTrials.gov NCT00707369).
10

Evidence and Implications of the Affordable Care Act for Racial/Ethnic Disparities in Diabetes Health During and Beyond the Pandemic

Lee, Jusung, Hale, Nathan L. 01 April 2022 (has links)
Amid the global pandemic, it becomes more apparent that diabetes is a pressing health concern because racial/ethnic minorities with underlying diabetes conditions have been disproportionately affected. The study proposes a multiyear examination to document the role of the Affordable Care Act (ACA) in racial/ethnic disparities in diabetes health. Using the Behavioral Risk Factor Surveillance System from 2011 to 2019, the study with a pre-post design investigated changes in access to care and diabetes health among non-White minorities compared with Whites before and after the ACA by conducting multivariable linear regression, with state-fixed effects and robust standard errors. Compared with Whites, racial/ethnic minorities showed significant improvements in health insurance coverage, having a personal doctor, and not seeing a doctor because of cost. Blacks (3.2% points,  ≤ 0.000), Hispanics (1.6% points,  = 0.001), and "other" racial/ethnic group (1.5% points,  = 0.003) experienced a greater increase in diagnosed prediabetes than Whites, whereas no and small differences were found in diagnosed diabetes and obesity, respectively. The yearly comparisons of changes in diagnosed prediabetes showed that Blacks compared with Whites had a growing increase from 1.2% points ( = 0.001) in 2014 to 3.3% points ( = 0.001) in 2019. Insurance coverage has declined after 2016, and obesity had an increasing trend across race/ethnicity. The ACA had a positive role in improving access to care and identifying those at risk for diabetes to a larger extent among racial/ethnic minorities. However, the policy impacts have been diminishing in recent years. Continued efforts are needed for sustained policy effects.

Page generated in 0.0346 seconds